|
Re: Question
David,
The trial that Chris directed you to is a phase III study involving both trastubzumab (Herceptin) and lapatinib (Tykerb) that is world wide. Dr. Edith Perez at Mayo Clinic in Jacksonville FL and a doctor Belgium are the principle investigators. Please look at the trial and give it serious consideration. I noticed three or four locations in Chile that are recruiting. The reason I know about this is because I just completed a stage II trial down at Mayo in Jacksonville. Lapatinib is also a targeted antibody like Herceptin, but it is an oral administration while Herceptin is intravenous. My lapatinib was provided free of charge while the Herceptin was billed to my insurance. I am sure if you contact one of the trial sites, they can give you a lot of information and assistance.
Good luck. Your friend is lucky to have you on her side.
Sandra
__________________
Diagnosed: 7/25/08 ~ age 63, no family history
Surgery: 8/14/08 Bilateral mastectomy; tumor left breast, node dissection; right prophylactic with expanders: 1/12/10 latisimuss dorsi flap on left side: 9/22/10 implants in
Pathology Report: ER/PR-; HER2+ (3+); Grade 3, StageIII; 3cm tumor plus 21/21 lymph nodes positive; 5cm DCIS
Chemo: A/C; Taxol/Herceptin/Tykerb; phase II study at Mayo adding Tykerb for early stage
Radiation: 25 rads
Vaccine: Walter Reed GP2/AE37 vaccine study ~ last booster 9/17/2012
|